Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Y9KR
|
||||
| Former ID |
DPR000112
|
||||
| Drug Name |
SSR-103800
|
||||
| Company |
Sanofi-Aventis
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium- and chloride-dependent glycine transporter 1 | Target Info | Blocker | [536463] | |
| WikiPathways | NRF2 pathway | ||||
| References | |||||
| Ref 468008 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4778). | ||||
| Ref 536463 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.